Patents by Inventor Michael T. Norman

Michael T. Norman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Beta lactamase as biomarker for the specific detection of tuberculosis-complex bacteria
    Patent number: 10962540
    Abstract: The present disclosure provides methods, reagents, systems, and devices that target ? lactamase as a biomarker for the sensitive and specific detection of tuberculosis-complex bacteria. Specifically, the present disclosure relates to methods and compositions for the detection of specific ?-lactamase protein and nucleic acid sequences to indicate the presence of tuberculosis-complex bacteria.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: March 30, 2021
    Assignee: The Texas A&M University System
    Inventors: Jeffrey D. Cirillo, Michael T. Norman
  • BETA LACTAMASE AS BIOMARKER FOR THE SPECIFIC DETECTION OF TUBERCULOSIS-COMPLEX BACTERIA
    Publication number: 20190101538
    Abstract: The present disclosure provides methods, reagents, systems, and devices that target ? lactamase as a biomarker for the sensitive and specific detection of tuberculosis-complex bacteria. Specifically, the present disclosure relates to methods and compositions for the detection of specific ?-lactamase protein and nucleic acid sequences to indicate the presence of tuberculosis-complex bacteria.
    Type: Application
    Filed: December 12, 2018
    Publication date: April 4, 2019
    Applicant: The Texas A&M University System
    Inventors: Jeffrey D. Cirillo, Michael T. Norman
  • Beta lactamase as biomarker for the specific detection of tuberculosis-complex bacteria
    Patent number: 10175239
    Abstract: The present disclosure provides methods, reagents, systems, and devices that target ? lactamase as a biomarker for the sensitive and specific detection of tuberculosis-complex bacteria. Specifically, the present disclosure relates to methods and compositions for the detection of specific ?-lactamase protein and nucleic acid sequences to indicate the presence of tuberculosis-complex bacteria.
    Type: Grant
    Filed: August 17, 2015
    Date of Patent: January 8, 2019
    Assignee: THE TEXAS A&M UNIVERSITY SYSTEM
    Inventors: Jeffrey D. Cirillo, Michael T. Norman
  • BETA LACTAMASE AS BIOMARKER FOR THE SPECIFIC DETECTION OF TUBERCULOSIS-COMPLEX BACTERIA
    Publication number: 20170350890
    Abstract: The present disclosure provides methods, reagents, systems, and devices that target ? lactamase as a biomarker for the sensitive and specific detection of tuberculosis-complex bacteria. Specifically, the present disclosure relates to methods and compositions for the detection of specific ?-lactamase protein and nucleic acid sequences to indicate the presence of tuberculosis-complex bacteria.
    Type: Application
    Filed: August 17, 2015
    Publication date: December 7, 2017
    Applicants: The Texas A&M University System, Global Biodiagnostics Corp.
    Inventors: Jeffrey D. Cirillo, Michael T. Norman